Search

Johnson Matthey and Bosch agree long-term collaboration on development of zero-emission hydrogen technology

Johnson Matthey acquires Formox

Johnson Matthey announces that it has completed the purchase of Formox AB (Formox) for SEK 1.05 billion (£107 million) in cash from Perstorp Specialty Chemicals AB, a company owned by PAI Partners

The importance of solid form science in modern drug development

As the pharmaceutical industry turns to more complex chemical entities with increased molecular weight, enhancing solubility is becoming a key drug development challenge.

Licensed process technology from Dow and Johnson Matthey selected for new butanol facility in China